Service Description

Evotec supports partners across the drug discovery and preclinical development continuum, from target validation and hit identification through lead optimization, candidate selection, IND-enabling studies, and early development planning.

Their capabilities include assay development, high-throughput screening, medicinal chemistry, structural biology, in vitro and in vivo pharmacology, ADME/DMPK, safety assessment, translational biology, and development-stage support.

This service is ideal for sponsors looking for an integrated scientific partner that can help move a therapeutic program from early discovery toward IND submission or clinical development.

Best For

Biotech companies, pharmaceutical companies, academic spinouts, and venture-backed programs seeking support across discovery, preclinical development, and early development planning.

Category

Drug Discovery & Preclinical Development

Tags

Drug discovery, preclinical development, IND-enabling, medicinal chemistry, assay development, ADME/DMPK, translational biology, lead optimization